Patricia Coyle, MD

Articles by Patricia Coyle, MD

Final Thoughts: Improving QoL in Multiple Sclerosis

ByPatricia Coyle, MD,June Halper, MSN, APC-C, MSCN, FAAN,Frederick Foley, PhD

February 5th 2021

Optimistic Outlook in Treating Multiple Sclerosis

ByPatricia Coyle, MD,June Halper, MSN, APC-C, MSCN, FAAN,Frederick Foley, PhD

February 5th 2021

Patient Support Networks for Multiple Sclerosis

ByPatricia Coyle, MD,June Halper, MSN, APC-C, MSCN, FAAN,Frederick Foley, PhD

February 5th 2021

OPTIMUM Trial for Multiple Sclerosis

ByPatricia Coyle, MD,June Halper, MSN, APC-C, MSCN, FAAN,Frederick Foley, PhD

February 5th 2021

TRIUMPHANT-MS Trial for Multiple Sclerosis

ByPatricia Coyle, MD,June Halper, MSN, APC-C, MSCN, FAAN,Frederick Foley, PhD

February 5th 2021

Multiple Sclerosis Fatigue

ByPatricia Coyle, MD,June Halper, MSN, APC-C, MSCN, FAAN,Frederick Foley, PhD

February 5th 2021

Quality of Life Issues: Cognitive Changes with MS

ByPatricia Coyle, MD,June Halper, MSN, APC-C, MSCN, FAAN,Frederick Foley, PhD

February 5th 2021

Patient’s Journey of Therapies for Multiple Sclerosis

ByPatricia Coyle, MD,June Halper, MSN, APC-C, MSCN, FAAN,Frederick Foley, PhD

February 5th 2021

Treatment Options Available for Multiple Sclerosis

ByPatricia Coyle, MD,June Halper, MSN, APC-C, MSCN, FAAN,Frederick Foley, PhD

February 5th 2021

Managing Psychological Symptoms of Multiple Sclerosis

ByPatricia Coyle, MD,June Halper, MSN, APC-C, MSCN, FAAN,Frederick Foley, PhD

February 5th 2021

Psychological Impact of Multiple Sclerosis

ByPatricia Coyle, MD,June Halper, MSN, APC-C, MSCN, FAAN,Frederick Foley, PhD

February 3rd 2021

Patient’s Journey: Diagnosis of Multiple Sclerosis

ByPatricia Coyle, MD,June Halper, MSN, APC-C, MSCN, FAAN,Frederick Foley, PhD

January 25th 2021

The Future of Treating Multiple Sclerosis

BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD

September 3rd 2020

Decision-Making Process for Treating Multiple Sclerosis

BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD

September 3rd 2020

Switching Therapies in Multiple Sclerosis

BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD

September 3rd 2020

Role of Ozanimod in Multiple Sclerosis

BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD

September 3rd 2020

Role of Diroximel Fumarate in Multiple Sclerosis

BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD

September 3rd 2020

Role of Ocrelizumab in Europe for Multiple Sclerosis

BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD

September 3rd 2020

Ocrelizumab for the Treatment of Multiple Sclerosis

BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD

September 3rd 2020

Role of Siponimod in Multiple Sclerosis

BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD

September 3rd 2020

Treating With Cladribine in Multiple Sclerosis

BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD

September 3rd 2020

Clinical Trials for Cladribine in Multiple Sclerosis

BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD

September 3rd 2020

The Use of Glatiramer Acetate in Multiple Sclerosis

BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD

September 3rd 2020

The Use of Interferon in Multiple Sclerosis

BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD

September 3rd 2020

First-Line Therapies for Relapsing Multiple Sclerosis

BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD

September 3rd 2020

Clinically Isolated Syndrome Versus Multiple Sclerosis

BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD

September 3rd 2020

MOG-IgG in Multiple Sclerosis

BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD

September 3rd 2020

Differential Diagnosis of Multiple Sclerosis

BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD

September 3rd 2020

Diagnosis of Multiple Sclerosis: The McDonald Criteria

BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD

September 3rd 2020